Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial
SB Calvert, JM Kramer, KJ Anstrom, LA Kaltenbach… - American heart …, 2012 - Elsevier
BACKGROUND: Nonadherence to cardiovascular medications is a significant public health
problem. This randomized study evaluated the effect on medication adherence of linking …
problem. This randomized study evaluated the effect on medication adherence of linking …
Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome
C Melloni, KP Alexander, FS Ou, NMA LaPointe… - The American journal of …, 2009 - Elsevier
Use of evidence-based medicine (EBM) improves outcomes after acute coronary syndromes
(ACS), yet patients often discontinue prescribed therapies after discharge. Although such …
(ACS), yet patients often discontinue prescribed therapies after discharge. Although such …
Drug discontinuation effects are part of the pharmacology of a drug
MM Reidenberg - Journal of Pharmacology and Experimental …, 2011 - ASPET
Most reviews of drug withdrawal effects focus on drugs of potential abuse such as opioids,
benzodiazepines, etc. Abrupt discontinuation of many other drugs used in medicine cause …
benzodiazepines, etc. Abrupt discontinuation of many other drugs used in medicine cause …
National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance
JM Kramer, B Hammill, KJ Anstrom, D Fetterolf… - American heart …, 2006 - Elsevier
BACKGROUND: Quality measures of evidence-based medications post–myocardial
infarction have focused on prescription at hospital discharge. Yet survival benefits of these …
infarction have focused on prescription at hospital discharge. Yet survival benefits of these …
Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes
N Rieckmann, IM Kronish, D Haas, W Gerin… - American heart …, 2006 - Elsevier
BACKGROUND: Even mild depressive symptoms during hospitalization are an independent
risk factor for mortality after acute coronary syndromes (ACS). The mortality risk is highest for …
risk factor for mortality after acute coronary syndromes (ACS). The mortality risk is highest for …
Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry
KAA Fox, FA Anderson Jr, SG Goodman… - Nature Clinical Practice …, 2008 - nature.com
Background The time course of events after acute coronary syndromes might influence the
timing and duration of therapeutic interventions. We investigated the impact of risk status …
timing and duration of therapeutic interventions. We investigated the impact of risk status …
Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis
M Lemstra, MW Alsabbagh - Patient preference and adherence, 2014 - Taylor & Francis
Purpose The World Health Organization (WHO) concluded that poor adherence to treatment
is the most important cause of uncontrolled high blood pressure, with approximately 75% of …
is the most important cause of uncontrolled high blood pressure, with approximately 75% of …
Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study
EV Ganse, L Laforest, E Alemao, G Davies… - … medical research and …, 2005 - Taylor & Francis
Background: Few studies have been conducted in actual clinical practice settings to
evaluate the ways in which dyslipidemia is managed using lipid-modifying therapies …
evaluate the ways in which dyslipidemia is managed using lipid-modifying therapies …
[HTML][HTML] The effect of text message reminders on medication adherence among patients with coronary heart disease: a systematic review and meta-analysis
YY Zhao, FP Dang, TT Zhai, HJ Li, RJ Wang, JJ Ren - Medicine, 2019 - journals.lww.com
Background: To determine the effectiveness of text message reminders (TMR) on
medication adherence (MA) and to investigate the effects of TMR on clinical outcomes …
medication adherence (MA) and to investigate the effects of TMR on clinical outcomes …
Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention
MA Hlatky, MD Solomon, D Shilane, TK Leong… - Journal of the American …, 2013 - jacc.org
Objectives: This study sought to compare use of evidence-based secondary preventive
medications after coronary bypass surgery (CABG) and percutaneous coronary intervention …
medications after coronary bypass surgery (CABG) and percutaneous coronary intervention …